| The MoCA: well-suited screen for cognitive impairment in Parkinson disease JC Dalrymple-Alford, MR MacAskill, CT Nakas, L Livingston, C Graham, ... Neurology 75 (19), 1717-1725, 2010 | 954 | 2010 |
| Grey matter atrophy in cognitively impaired Parkinson's disease TR Melzer, R Watts, MR MacAskill, TL Pitcher, L Livingston, RJ Keenan, ... Journal of Neurology, Neurosurgery & Psychiatry 83 (2), 188-194, 2012 | 311 | 2012 |
| Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson’s disease TR Melzer, R Watts, MR MacAskill, JF Pearson, S Rüeger, TL Pitcher, ... Brain 134 (3), 845-855, 2011 | 202 | 2011 |
| Characterizing mild cognitive impairment in Parkinson's disease JC Dalrymple‐Alford, L Livingston, MR MacAskill, C Graham, TR Melzer, ... Movement Disorders 26 (4), 629-636, 2011 | 185 | 2011 |
| White matter microstructure deteriorates across cognitive stages in Parkinson disease TR Melzer, R Watts, MR MacAskill, TL Pitcher, L Livingston, RJ Keenan, ... Neurology 80 (20), 1841-1849, 2013 | 177 | 2013 |
| Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study CJL Heron, SL Wright, TR Melzer, DJ Myall, MR MacAskill, L Livingston, ... Journal of Cerebral Blood Flow & Metabolism 34 (6), 964-970, 2014 | 81 | 2014 |
| Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study KL Wood, DJ Myall, L Livingston, TR Melzer, TL Pitcher, MR MacAskill, ... npj Parkinson's Disease 2 (1), 1-8, 2016 | 75 | 2016 |
| The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease MR MacAskill, CF Graham, TL Pitcher, DJ Myall, L Livingston, ... Neuropsychologia 50 (14), 3338-3347, 2012 | 72 | 2012 |
| Beta amyloid deposition is not associated with cognitive impairment in Parkinson's disease TR Melzer, MR Stark, RJ Keenan, DJ Myall, MR MacAskill, TL Pitcher, ... Frontiers in neurology 10, 391, 2019 | 65 | 2019 |
| Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI) AJ Jones, RG Kuijer, L Livingston, D Myall, K Horne, M MacAskill, ... Translational Neurodegeneration 6, 1-9, 2017 | 65 | 2017 |
| The MoCA: well-suited screen for cognitive impairment in Parkinson disease J Marinus, JC Dalrymple-Alford, D Verbaan, JJ van Hilten, CT Nakas, ... Neurology 76 (22), 1944-1945, 2011 | 27 | 2011 |
| Tracking Parkinson’s disease over one year with multimodal magnetic resonance imaging in a group of older patients with moderate disease TR Melzer, DJ Myall, MR MacAskill, TL Pitcher, L Livingston, R Watts, ... PloS one 10 (12), e0143923, 2015 | 26 | 2015 |
| Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting M Almuqbel, TR Melzer, DJ Myall, MR MacAskill, TL Pitcher, L Livingston, ... Parkinsonism & related disorders 22, 54-61, 2016 | 20 | 2016 |
| Comparison of cognitive and UHDRS measures in monitoring disease progression in Huntington’s disease: a 12-month longitudinal study EA Toh, MR MacAskill, JC Dalrymple-Alford, DJ Myall, L Livingston, ... Translational Neurodegeneration 3, 1-10, 2014 | 19 | 2014 |
| Neuropsychiatric symptoms are associated with dementia in Parkinson's disease but not predictive of it KL Horne, MR MacAskill, DJ Myall, L Livingston, S Grenfell, MJ Pascoe, ... Movement Disorders Clinical Practice 8 (3), 390-399, 2021 | 9 | 2021 |
| Higher perceived stress and exacerbated motor symptoms in Parkinson’s disease during the COVID-19 lockdown in New Zealand RL Blakemore, MJ Pascoe, KL Horne, L Livingston, BN Young, B Elias, ... NZ Med J 134 (1538), 44-51, 2021 | 7 | 2021 |
| The New Zealand Parkinson’s progression programme MR MacAskill, TL Pitcher, TR Melzer, DJ Myall, KL Horne, R Shoorangiz, ... Journal of the Royal Society of New Zealand 53 (4), 466-488, 2023 | 3 | 2023 |
| Idiopathisches Parkinson-Syndrom F Marxreiter, J Winkler Nervenheilkunde 33 (10), 710-718, 2014 | 2 | 2014 |
| MRI to investigate cerebrovascular changes in Parkinson's disease D Nolan, D Myall, C Morgan, R Shoorangiz, L Livingston, S Grenfell, ... MOVEMENT DISORDERS 37, S87-S87, 2022 | | 2022 |
| EEG power-spectra parametrization and cognitive ability in Parkinson's disease R Shoorangiz, N Slater, G Hall-McMaster, E Peterson, L Livingston, ... MOVEMENT DISORDERS 37, S94-S95, 2022 | | 2022 |
